Guilin Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guilin Wang has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Horace H. Loh
2 shared publicationsLi-Na Wei
2 shared publications- Ping-Yee Law
Department of Pharmacology, University of Minnesota, Minneapolis, USA
1 shared publication Tiancheng Liu
1 shared publication
Latest Publications
- 1 June 2005
- Published by Elsevier in Molecular Pharmacology
- Vol. 67 (6) , 2032-2039
DNA Methylation-Related Chromatin Modification in the Regulation of Mouse δ-Opioid Receptor Gene
DNA methylation plays critical roles in gene-silencing through chromatin modification. We reported previously that promoter-region CpG methylation repressed mouse δ-opioid receptor (mDOR) gene expression. In the current study, we demonstrated that the methylation of mDOR gene promoter is correlated with a repressive chromatin structure that has less HaeIII and MspI nuclear accessibility and more deacetylated histone H3 and H4 than that of unmethylated mDOR promoter. Chromatin immunoprecipitation analysis showed the association of a methyl-CpG-binding domain protein 2 (MBD2) with methylated mDOR promoter. Transient expression of MBD2 enhanced the repression of partially methylated mDOR promoter activity, and this repression was partially reversed by treatment of trichostatin A, a specific histone deacetylase inhibitor, indicating that MBD2 may mediate DNA methylation-related chromatin modification through recruiting histone deacetylases to mDOR promoter region. In addition, trichostatin A treatment increased both methylated mDOR promoter activity in a transient transfection assay and endogenous mDOR mRNA level in Neuro2A cells. Taken together, these results demonstrate that the mDOR gene expression is regulated by DNA methylation-related chromatin modification, especially histone acetylation and deacetylation.
- 1 June 2005
- Published by Elsevier in Molecular Pharmacology
- Vol. 67 (6) , 2032-2039
DNA Methylation-Related Chromatin Modification in the Regulation of Mouse δ-Opioid Receptor Gene
DNA methylation plays critical roles in gene-silencing through chromatin modification. We reported previously that promoter-region CpG methylation repressed mouse δ-opioid receptor (mDOR) gene expression. In the current study, we demonstrated that the methylation of mDOR gene promoter is correlated with a repressive chromatin structure that has less HaeIII and MspI nuclear accessibility and more deacetylated histone H3 and H4 than that of unmethylated mDOR promoter. Chromatin immunoprecipitation analysis showed the association of a methyl-CpG-binding domain protein 2 (MBD2) with methylated mDOR promoter. Transient expression of MBD2 enhanced the repression of partially methylated mDOR promoter activity, and this repression was partially reversed by treatment of trichostatin A, a specific histone deacetylase inhibitor, indicating that MBD2 may mediate DNA methylation-related chromatin modification through recruiting histone deacetylases to mDOR promoter region. In addition, trichostatin A treatment increased both methylated mDOR promoter activity in a transient transfection assay and endogenous mDOR mRNA level in Neuro2A cells. Taken together, these results demonstrate that the mDOR gene expression is regulated by DNA methylation-related chromatin modification, especially histone acetylation and deacetylation.
- Open Access
- 1 October 2003
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (42) , 40550-40556
Transcriptional Regulation of Mouse δ-Opioid Receptor Gene by CpG Methylation
- 1 October 2003
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (42) , 40550-40556
Open AccessTranscriptional Regulation of Mouse δ-Opioid Receptor Gene by CpG Methylation